Targeted CEA CAR-T

BIOLOGICAL4 trials

Sponsors

Chongqing Precision Biotech Co., Ltd

Conditions

Advanced Lung Cancer

Phase 1

A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer

RecruitingNCT06768151

Chongqing Precision Biotech Co., LtdAdvanced Lung Cancer

Start: 2024-12-12End: 2027-12-31Target: 48Updated: 2025-01-10

Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma

RecruitingNCT06903117

Chongqing Precision Biotech Co., LtdAdvanced Lung Cancer

Start: 2025-03-24End: 2028-03-31Target: 60Updated: 2025-04-03

Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer

RecruitingNCT06945523

Chongqing Precision Biotech Co., LtdAdvanced Lung Cancer

Start: 2025-04-28End: 2028-04-30Target: 60Updated: 2025-06-04

Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

RecruitingNCT06992583

Chongqing Precision Biotech Co., LtdAdvanced Lung Cancer

Start: 2025-05-08End: 2028-04-30Target: 60Updated: 2025-05-28